(Q48233735)

9 February 2018

title

Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. (English)

1 reference

9 February 2018

0 references

1 reference

1 reference

4

1 reference

9 February 2018

author name string

Plato Mak

series ordinal

1

1 reference

9 February 2018

Christina Broussard

series ordinal

2

1 reference

9 February 2018

Kristina Vacy

series ordinal

3

1 reference

9 February 2018

language of work or name

English

0 references

publication date

2 September 2011

1 reference

9 February 2018

Journal of Psychopharmacology

published in

1 reference

9 February 2018

volume

26

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

532-542

1 reference

9 February 2018

Anxiety and stress responses in female oxytocin deficient mice

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Blood-brain barrier and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Trial 2 in the elevated plus-maze: a different form of fear?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

The vasopressin system--from antidiuresis to psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Diazepam disposition determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Oxytocin, vasopressin, and autism: is there a connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Female Oxytocin-Deficient Mice Display Enhanced Anxiety-Related Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

An anxiolytic action of oxytocin is enhanced by estrogen in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Short-term behavioral effects of posterior pituitary peptides in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Brain oxytocin: a key regulator of emotional and social behaviours in both females and males

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

The central vasopressinergic system: examining the opportunities for psychiatric drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Basis and therapeutical rationale of the urinary concentrating mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Anticonflict and rotarod impairing effects of alprazolam and diazepam in rat after acute and subchronic administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Oxytocin and vasopressin hexapeptide fragments have opposing influences on conditioned freezing behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Evidence that tolerance develops to the anxiolytic effect of diazepam in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Oxytocin may mediate the benefits of positive social interaction and emotions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

The psychobiology of emotion: the role of the oxytocinergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Inhibitory and stimulatory action of vasopressin on the secretion of corticotrophin in rats: Structure-activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Centrally released oxytocin mediates mating-induced anxiolysis in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

The use of the elevated plus maze as an assay of anxiety-related behavior in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

Vasopressin and oxytocin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111416687

21 January 2018

Identifiers

DOI

10.1177/0269881111416687

1 reference

9 February 2018

1 reference

9 February 2018